SCHEMBL6617397

SCHEMBL6617397

Cc1ccc(-c2cnc3cc4[nH]ncc4cc3n2)c(C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 2/20 0.44
▸ MAPT P10636 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ ATM Q13315 2/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ MAPK10 P53779 1/20 0.43
▸ POLB P06746 1/20 0.41
▸ TRPA1 O75762 2/20 0.41
▸ MAPK1 P28482 3/20 0.40
▸ TRPM8 Q7Z2W7 1/20 0.40
▸ TRPV1 Q8NER1 1/20 0.40
▸ FLT3 P36888 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ ROCK2 O75116 2/20 0.38
▸ GSK3B P49841 2/20 0.38
▸ AURKA O14965 1/20 0.38
▸ PRKCG P05129 1/20 0.38
▸ CDK1 P06493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6618800 1.00 FGFR1 (0.44) FGFR1MAPTALDH1A1MEN1KMT2A
SCHEMBL8103281 0.94 FGFR1 (0.45) FGFR1MAPTALDH1A1MEN1KMT2A
SCHEMBL8110919 0.85 TRPA1 (0.55) FGFR1MAPTALDH1A1MEN1KMT2A
SCHEMBL6621847 0.85 TRPA1 (0.55) FGFR1MAPTALDH1A1MEN1KMT2A
SCHEMBL6618925 0.85 TRPA1 (0.55) FGFR1MAPTALDH1A1MEN1KMT2A
SCHEMBL6618612 0.82 MAPK1 (0.49) FGFR1MAPTALDH1A1TRPA1MAPK1
SCHEMBL6621230 0.82 MAPK1 (0.49) FGFR1MAPTALDH1A1TRPA1MAPK1
SCHEMBL6619870 0.79 BCHE (0.54) FGFR1MAPTALDH1A1MEN1KMT2A
SCHEMBL6617130 0.79 BCHE (0.54) FGFR1MAPTALDH1A1MEN1KMT2A
SCHEMBL6617887 0.77 NPC1 (0.57) FGFR1MAPTALDH1A1TRPA1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE AVENTIS PHARMA INC (US) 2004-06-23 — — EP disclosed
US-5476851-A Administering as therapeutic agents for various disease states which are characterized by uncontrolled cellular proliferation RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1995-12-19 — — US disclosed
Send feedback